Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
The Journal of Biological Chemistry|September 10, 1983
Phosphoprotein phosphatases in human erythrocyte cytosolH Usui, N Kinohara, K Yoshikawa, et al.Diabetes, Obesity & Metabolism|December 15, 2015
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III studyM Odawara, J Miyagawa, N Iwamoto, et al.Neuroscience Research|September 1, 1994
Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's diseaseI Date, Y Miyoshi, T Imaoka, et al.Cancer|February 15, 1983
Pedunculated hepatocellular carcinoma. Report of three cases and review of literatureY Horie, S Katoh, H Yoshida, et al.Japanese Journal of Cancer Research : Gann|February 1, 1989
Antitumor activity of BOF-A2, a new 5-fluorouracil derivativeS Fujii, M Fukushima, Y Shimamoto, et al.Diabetes, Obesity & Metabolism|July 17, 2015
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III studyJ Miyagawa, M Odawara, T Takamura, et al.Journal of Neurosurgery|April 1, 1996
Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case reportI Date, T Imaoka, Y Miyoshi, et al.The Journal of Antibiotics|April 1, 1994
Antitumor effect of piericidin B1 N-oxideH Nishioka, M Imoto, T Imaoka, et al.Journal of Endocrinological Investigation|December 22, 2011
Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary glandT Imaoka, H Hisatsune, Y Sakanishi, et al.European Journal of Biochemistry|September 1, 1979
The control of phosphoprotein phosphatase by the second-site phosphorylation of a substrate. Studies with H2B histone as model substrateH Usui, N Nishimura, M Imazu, et al.Pageof 7